PSP94Prostate Secretory Protein of 94 Amino Acids
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
has reached an important milestone in identifying the Prostate Secretory Protein of 94 amino acids (PSP94) binding protein.
In a previous peer-reviewed publication, Procyon's collaborating scientists demonstrated that pre-treatment blood measurements of bound and free PSP94 can accurately separate prostate cancer patients treated with curative intent radiotherapy into "good" and "bad" prognostic groups.
The Japanese patent covers the use of PSP94 as an anti-cancer therapeutic.